American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S373-S383 , December 2008

The clinical content of preconception care: reproductive history

  • Phillip G. Stubblefield, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Boston University Medical Center, Boston, MA
    • Corresponding Author InformationReprints: Phillip G. Stubblefield, MD, Boston Medical Center, DOB 720 Harrison Ave, Suite 1105, Boston, MA 02118
    • ,
  • Dean V. Coonrod, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Maricopa Medical Center, Phoenix, AZ
    • ,
  • Uma M. Reddy, MD, MPH

      Affiliations

    • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
    • ,
  • Raja Sayegh, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Boston University Medical Center, Boston, MA
    • ,
  • Wanda Nicholson, MD, MPH, MBA

      Affiliations

    • Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD
    • ,
  • Daniel F. Rychlik, MD

      Affiliations

    • Fertility Treatment Center, Tempe, AZ
    • ,
  • Brian W. Jack, MD

      Affiliations

    • Department of Family Medicine, Boston University School of Medicine, Boston, MA

Received 17 June 2008 ,Revised 15 October 2008 ,Accepted 17 October 2008.

References 

  1. Fowler JR, Jack BW. Preconception care. In:  Taylor RB,  David AK,  Fields SA,  Phillips DM,  Scherger JE editor. Family medicine principles and practice. 6th ed.. New York (NY): Springer; 2003;p. 85–94
  2. American College of Obstetricians and Gynecologists. ACOG technical bulletin: preconceptional care. Int J Gynaecol Obstet. 1995;50:201–207
  3. Surkan PJ, Stephansson O, Dickman PW, Cnattingius S. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth. N Engl J Med. 2004;350:777–785
  4. Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep. 2003;52:1–85
  5. Fedrick J, Anderson ABM. Factors associated with spontaneous preterm birth. Br J Obstet Gynaecol. 1976;83:342–350
  6. Bakketeig LS, Hoffman HG, Harley EE. The tendency of repeats gestational age and birth weight in successive births. Am J Obstet Gynecol. 1979;135:1086–1103
  7. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP. Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. Am J Obstet Gynecol. 1990;162:213–218
  8. Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol. 2007;110:405–415
  9. Bloom SL, Yost NP, McIntire DD, Leveno KJ. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98:379–385
  10. Mercer BM, Goldenberg RL, Moawad AW, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. Am J Obstet Gynecol. 1999;181:1216–1221
  11. Coonrod DV, Jack BW, Stubblefield PG, et al. The clinical content of preconception care: infectious diseases in preconception care. Am J Obstet Gynecol. 2008;199:S296–S309
  12. Reddy UM. Prediction and prevention of recurrent stillbirth. Obstet Gynecol. 2007;110:1151–1164
  13. Berghella V. Prevention of recurrent fetal growth restriction. Obstet Gynecol. 2007;110:904–912
  14. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. ACOG practice bulletin 12 Washington (DC): American College of Obstetricians and Gynecologists; 2000;
  15. Kinzler WL, Kaminsky L. Fetal growth restriction and subsequent pregnancy risks. Semin Perinatol. 2007;31:126–134
  16. Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network N Engl J Med. 1996;334:567–572
  17. Clinical Management Guidelines for Obstetrician-Gynecologists. ACOG practice bulletin no. 48, 2003 Obstet Gynecol. 2003;102:1091–1099
  18. Gardiner PM, Nelson L, Shellhaas CS, et al. The clinical content of preconception care: nutrition and dietary supplements. Am J Obstet Gynecol. 2008;199:S345–S356
  19. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. (Cochrane Review) In: The Cochrane Library, Issue 4. Oxford (UK): Update Software; 2004;
  20. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cereclage. MRC/RCOG Working Party on Cervical Cerclage Br J Obstet Gynecol. 1993;1006:516–523
  21. Drakeley AJ, Roberts D, Alfirevic Z. Cervical cerclage for prevention of preterm delivery: meta-analysis of randomized trials. Obstet Gynecol. 2004;102:621–627
  22. Berghellla V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005;106:181–189
  23. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17-alpha hydroxyprogesterone caproate. N Engl J Med. 2003;248:2379–2385
  24. DaFonseca EB, Birrar RE, Carvalho MH, Zugaib M. Prophylactic administration by vaginal suppository to reduce the incidence of preterm birth in women at increased risk: a randomized placebo-controlled double blind study. Am J Obstet Gynecol. 2003;1884:419–424
  25. Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol. 2005;105:273–279
  26. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides MD. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462–469
  27. Wakine Y. New orphan drugs: Gestiva, Onconase, aerosolized Ciprofloxacin. Med Scape Today. 2007;Feb. 26, http://www.medscape.com/viewarticle/552771 Accessed Nov. 8, 2008
  28. Use of progesterone to reduce preterm birth. ACOG committee opinion no. 21, November 2003 Obstet. Gynecol. 2003;102:1115–1116
  29. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. ACOG practice bulletin 12 Washington, DC: American College of Obstetricians and Gynecologists; 2000;
  30. Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med. 2004;351:2581–2589
  31. Mercer BM, Gilbert S, Landon MB, et al. Labor outcomes with increasing number of prior vaginal births after cesarean delivery. Obstet Gynecol. 2008;111(2 Pt 1):285–291
  32. Bujold E, Gauthier RJ. Neonatal morbidity associated with uterine rupture: what are the risk factors?. Am J Obstet Gynecol. 2002;186:311–314
  33. Bujold E, Bujold C, Hamilton EF, Harel F, Gauthier RJ. The impact of a single-layer or double-layer closure on uterine rupture. Am J Obstet Gynecol. 2002;186:1326–1330
  34. Kieser KE, Baskett TF. A 10-year population-based study of uterine rupture. Obstet Gynecol. 2002;100:749–753
  35. Hibbard JU, Gilbert S, Landon MB, et al. Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol. 2006;108:125–133
  36. Getahun D, Oyelese Y, Salihu HM, Ananth CV. Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol. 2006;107:771–778
  37. Grobman WA, Gersnoviez R, Landon MB, et al. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol. 2007;110:1249–1255
  38. Naef RW, Ray MA, Chauhan SP, Roach H, Blake PG, Martin JN. Trial of labor after cesarean delivery with a lower-segment, vertical uterine incision: is it safe?. Am J Obstet Gynecol. 1995;172:1666–1673discussion 1673-4
  39. de Costa C. Vaginal birth after classical cesarean. Aust New Z J Obstet Gynecol. 2005;45:182–186
  40. Macones GA, Peipert J, Nelson DB, et al. Maternal complications with vaginal birth after cesarean delivery: a multicenter study. Am J Obstet Gynecol. 2005;193:1652–1662
  41. Gyamfi C, Juhasz G, Gyamfi P, Blumenfeld Y, Stone JL. Single- versus double-layer uterine incision closure and uterine rupture. J Matern Fetal Neonatal Med. 2006;19:639–643
  42. Pruett KM, Kirshon B, Cotton DB. Unknown uterine scar and trial of labor. Am J Obstet Gynecol. 1988;159:807–810
  43. Chapman ST, Owen J, Hauth JC. Once versus two layer closure of a low transverse cesarean: the next pregnancy. Obstet Gynecol. 1997;89:16–28
  44. Durnwald C, Mercer B. Uterine rupture, perioperative and perinatal morbidity after single and double layer closure at cesarean delivery. Am J Obstet Gynecol. 2003;189:925–929
  45. Tucker JM, Hauth JC, Hodgkins P, et al. Trial of labor after a one- or two-layer closure of a low transverse uterine incision. Am J Obstet Gynecol. 1993;168:545–546
  46. Shipp TD, Zelop C, Cohen A, et al. Post-cesarean delivery fever and uterine rupture in a subsequent trial of labor. Obstet Gynecol. 2003;101:136–139
  47. Shipp TD, Zelop C, Repke JT, Cohen A, Caughey AB, Lieberman E. The association of maternal age and symptomatic uterine rupture during a trial of labor after prior cesarean delivery. Obstet Gynecol. 2002;99:585–588
  48. Bujold E, Mehta SH, Bujold C, Gauthier RJ. Interdelivery interval and uterine rupture. Am J Obstet Gynecol. 2002;187:1199–1202
  49. Shipp TD, Zelop CM, Repke JT, Cohen A, Lieberman E. Interdelivery interval and risk of symptomatic uterine rupture. Obstet Gynecol. 2001;97:175–177
  50. Stamilio DM, DeFranco E, Paré E, et al. Short interpregnancy interval (Risk of uterine rupture and complications of vaginal birth after cesarean delivery). Obstet Gynecol. 2007;110:1075–1082
  51. ACOG committee opinion no. 342: induction of labor for vaginal birth after cesarean delivery. Obstet Gynecol. 2006;108:465–468
  52. Rochelson B, Pagano M, Conetta L, et al. Previous preterm cesarean delivery: identification of a new risk factor for uterine rupture in VBAC candidates. J Matern Fetal Neonatal Med. 2005;18:339–342
  53. Landon MB, Spong CY, Thom E, et al. Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol. 2006;108:12–20
  54. Shipp TD, Zelop C, Lieberman E. Assessment of the rate of uterine rupture at the first prenatal visit: a preliminary evaluation. J Matern Fetal Neonatal Med. 2008;221:129–133
  55. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accrete. Obstet Gynecol. 2006;108(3 Pt 1):573–581
  56. Christiansen OB, Nybo Andersen AM, Bosch E, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005;83:821–839
  57. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2004;7
  58. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216–2222
  59. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. 1984;148:140–146
  60. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. 1997;12:387–389
  61. Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss. The Practice Committee of the American Society for Reproductive Medicine Fertil Steril. 2006;86(Suppl 4):S226–S227
  62. National Center for Health Statistics. State definitions and reporting requirements for live births, fetal deaths, and induced terminations of pregnancy. 1997 revision In: Hyattsville, MD: National Center for Health Statistics; 1997;p. 9
  63. MacDorman MF, Hoyert DL, Martin JA, Munson ML, Hamilton BE. Fetal and perinatal mortality, United States, 2003. National vital statistics reports; vol 55 Hyattsville, MD: National Center for Health Statistics; 2007;
  64. Greenwood R, Samms-Vaughan M, Golding J, Ashley D. Past obstetric history and risk of perinatal death in Jamaica. Paediatr Perinat Epidemiol. 1994;8(Suppl 1):40–53
  65. Samueloff A, Xenakis EM, Berkus MD, Huff RW, Langer O. Recurrent stillbirth (Significance and characteristics). J Reprod Med. 1993;38:883–886
  66. Sharma PP, Salihu HM, Oyelese Y, Ananth CV, Kirby RS. Is race a determinant of stillbirth recurrence?. Obstet Gynecol. 2006;107:391–397
  67. Heinonen S, Kirkinen P. Pregnancy outcome after previous stillbirth resulting from causes other than maternal conditions and fetal abnormalities. Birth. 2000;27:33–37
  68. Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol. 2005;193:1923–1935
  69. Smith GC, Crossley JA, Aitken DA, et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA. 2004;292:2249–2254
  70. Gris JC, Mercier E, Quere I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103:3695–3699
  71. Frias AE, Luikenaar RA, Sullivan AE, et al. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol. 2004;104:521–526
  72. Waller DK, Lustig LS, Smith AH, Hook EB. Alpha-fetoprotein: a biomarker for pregnancy outcome. Epidemiology. 1993;4:471–476
  73. Walton DL, Norem CT, Schoen EJ, Ray GT, Colby CJ. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. N Engl J Med. 1999;341:2033–2038
  74. American College of Obstetricians and Gynecologists practice bulletin. Intrauterine growth restriction. Number 12 In: Washington, DC: American College of Obstetricians and Gynecologists; 2000;p. 591–600
  75. Weeks JW, Asrat T, Morgan MA, Nageotte M, Thomas SJ, Freeman RK. Antepartum surveillance for a history of stillbirth: when to begin?. Am J Obstet Gynecol. 1995;172:486–492
  76. Hankins GD, Longo M. The role of stillbirth prevention and late preterm (near-term) births. Semin Perinatol. 2006;30:20–23
  77. Korteweg FJ, Bouman K, Erwich JJ, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic work up. Obstet Gynecol. 2008;111:865–874
  78. ACOG committee opinion no. 383. Evaluation of stillbirths and neonatal deaths Obstet Gynecol. 2007;110:963–966
  79. Ventura SJ, Hamilton BE, Mathews TJ, Chandra A. Trends and variations in smoking during pregnancy and low birth weight: evidence from the birth certificate, 1990-2000. Pediatrics. 2003;111(5 Part 2):1176–1180
  80. Iverson RE, DeCherney AH, Laufer MR. Clinical manifestations and diagnosis of congenital anomalies of the uterus. http://uptodateonline.com2007;Accessed May 1, 2008
  81. Simon C, Martinez L, Pardo F, Tortajada M. Müllerian defects in women with normal reproductive outcome. Fertil Steril. 1991;56:1192
  82. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2001;7:161–174
  83. Acien P. Reproductive performance of women with uterine malformations. Hum Reprod. 1993;8:122
  84. Nahum GG. Uterine malformations: how common are they and what is their distribution among subtypes?. J Reprod Med. 1998;43:877–887
  85. Raga F, Bonilla-Musoles F, Blanes J, Osborne NG. Congenital mullerian anomalies: diagnostic accuracy of three-dimensional ultrasound. Fertil Steril. 1996;65:523
  86. Pellerito JS, McCarthy SM, Doyle MB, Glickman MG, DeCherney AH. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology. 1992;183:795–800
  87. Daly DC, Maier D, Soto-Albors C. Hysteroscopic metroplasty: six years experience. Obstet Gynecol. 1989;73:2001
  88. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril. 2000;74:1–14
  89. Lolis DE, Paschopoulos M, Makrydimas G, Zikopoulos K, Sotiriadis A, Paraskevaidis E. Reproductive outcome after strassman metroplasty in women with a bicornuate uterus. J Reprod Med. 2005;50:297–301
  90. Ludmir J, Samuels P, Brooks S, Mennuti MT. Pregnancy outcomes of patients with uncorrected uterine anomalies managed in a high risk obstetric setting. Obstet Gynecol. 1990;75:906–910
  91. Lin PC. Reproductive outcomes in women with uterine anomalies. J Womens Health. 2004;13:33–39

 The views expressed herein are those of the authors and do not necessarily reflect those of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.

 Conflict of Interest: Phillip G. Stubblefield, MD; Uma M. Reddy, MD, MPH; Raja Sayegh, MD; Wanda Nicholson, MD, MPH, MBA; Daniel F. Rychlik, MD; and Brian W. Jack, MD have no conflict of interest including grants, honoraria, advisory board membership, or share holdings. Dean V. Coonrod, MD, MPH is a Grant Recipient from the March of Dimes Arizona Chapter to develop an internatal Care Clinic and has funding from CMS (#1HOCMS030207 101) working on compliance with the 6 week postpartum visit as a strategy to improve preconception care.

PII: S0002-9378(08)02075-9

doi: 10.1016/j.ajog.2008.10.048

American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S373-S383 , December 2008

Article Tools